1. Home
  2. MRVI vs SMWB Comparison

MRVI vs SMWB Comparison

Compare MRVI & SMWB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Maravai LifeSciences Holdings Inc.

MRVI

Maravai LifeSciences Holdings Inc.

HOLD

Current Price

$3.80

Market Cap

472.8M

Sector

Health Care

ML Signal

HOLD

Logo Similarweb Ltd.

SMWB

Similarweb Ltd.

HOLD

Current Price

$2.70

Market Cap

240.7M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
MRVI
SMWB
Founded
2014
2007
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Programming Data Processing
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
472.8M
240.7M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
MRVI
SMWB
Price
$3.80
$2.70
Analyst Decision
Buy
Buy
Analyst Count
7
7
Target Price
$4.57
$8.13
AVG Volume (30 Days)
1.1M
1.8M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
14.29
N/A
EPS
N/A
N/A
Revenue
$185,743,000.00
N/A
Revenue This Year
$11.80
$17.15
Revenue Next Year
$7.74
$14.61
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.67
$2.22
52 Week High
$4.11
$10.75

Technical Indicators

Market Signals
Indicator
MRVI
SMWB
Relative Strength Index (RSI) 69.37 24.91
Support Level $3.65 $2.22
Resistance Level $4.03 $7.92
Average True Range (ATR) 0.18 0.34
MACD 0.10 0.05
Stochastic Oscillator 92.23 23.02

Price Performance

Historical Comparison
MRVI
SMWB

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

About SMWB Similarweb Ltd.

Similarweb Ltd provides digital data and analytics that power critical business decisions. The group recognizes revenue from subscriptions to the platform and other subscription products on a straight-line basis over the term of the contract subscription period beginning on the date access to the platform is granted, provided all other revenue recognition criteria have been met. It has geographic presence in Israel, the United States, the United Kingdom, Asia Pacific, Europe, and Other. The group generates the majority of its revenue from the United States.

Share on Social Networks: